D70.1
BillableAgranulocytosis secondary to cancer chemotherapy
Agranulocytosis secondary to cancer chemotherapy
Coding Notes
Includes
Conditions included under this code
- agranulocytosis
- decreased absolute neurophile count (ANC)
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Excludes 2
Conditions not included here, but the patient may have both
- •autoimmune disease (systemic) NOSM35.9
- •certain conditions originating in the perinatal periodP00-P96
- •complications of pregnancy, childbirth and the puerperiumO9A)O00
- •congenital malformations, deformations and chromosomal abnormalitiesQ00-Q99
- •endocrine, nutritional and metabolic diseasesE00-E88
- •human immunodeficiency virus [HIV] diseaseB20
- •injury, poisoning and certain other consequences of external causesS00-T88
- •neoplasmsC00-D49
- •symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classifiedR00-R94
Use Additional Code
Additional codes that should follow this code
- code for any associated:
- •feverR50.81
- •code for adverse effect, if applicable, to identify drugX5)T45.1
Code Also
A second code may be required; sequencing depends on circumstances
- •, if applicable, mucositis, , ,J34.81, K12.3, K92.81, N76.81
- underlying neoplasm
Related Codes(6)
Also Known As / Clinical Terms(13)
SNOMED CT
- Agranulocytosis17182001
- Schultz disease17182001
- Neutropaenia due to and following chemotherapy767658000
- Neutropenia due to and following chemotherapy767658000
- Agranulocytosis due to and following administration of antineoplastic agent350691000119103
- Agranulocytosis due to and following cancer chemotherapy350691000119103
Clinical Terms
- Agranulocytosis
- Neutropenia due to and following chemotherapy
- Neutropaenia due to and following chemotherapy
- Schultz disease
- Agranulocytosis due to and following administration of antineoplastic agent
- Agranulocytosis due to and following cancer chemotherapy
Frequently Asked Questions
What is the ICD-10 code for agranulocytosis secondary to cancer chemotherapy?
The ICD-10-CM code for agranulocytosis secondary to cancer chemotherapy is D70.1. The full clinical description is "Agranulocytosis secondary to cancer chemotherapy". D70.1 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code D70.1 mean?
ICD-10-CM code D70.1 represents “Agranulocytosis secondary to cancer chemotherapy”. It is classified under Chapter 3: Diseases of the Blood and Blood-Forming Organs and is a billable/specific code that can be used on a claim.
Is D70.1 a billable code?
Yes, D70.1 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is D70.1 in?
D70.1 is in Chapter 3: Diseases of the Blood and Blood-Forming Organs (codes D50-D89).
What codes cannot be used with D70.1?
D70.1 has Excludes1 notes indicating codes that cannot be used together with it, including: neutropenic splenomegaly (D73.81); transient neonatal neutropenia (P61.5).
Are additional codes required with D70.1?
Yes, when using D70.1, also report: any associated:; fever (R50.81); adverse effect, if applicable, to identify drug (T45.1X5).
What SNOMED CT codes does D70.1 map to?
D70.1 maps to 3 SNOMED CT concepts: 17182001, 350691000119103, 767658000. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for D70.1?
D70.1 is linked to 1 UMLS Concept Unique Identifier: C2873810. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does D70.1 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like agranulocytosis secondary to cancer chemotherapy affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of D70.1?
There is no direct ICD-11 mapping available for D70.1 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.